Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (97)
Leukemia (12)
Blood Cancer Journal (6)
Nature (2)
Oncogene (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (99)
Correspondence (9)
Reviews (8)
Amendments and Corrections (6)
Comments & Opinion (2)
Special Features (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Developmental biology
Diseases
Ecology
Genetics
Health care
Immunology
Medical research
Microbiology
Molecular biology
Plant sciences
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 125 results

Advanced filters: Author: Didier Blaise Clear advanced filters

Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years

Mathias Debals-Gonthier
Carole Siani
Anne-Gaëlle Le Corroller Soriano
Research09 Mar 2018
Bone Marrow Transplantation

Volume: 53, P: 1096-1104
Stabilization of sea urchin flagellar microtubules by histone H1

Luc Multigner
Jean Gagnon
Didier Job
Research05 Nov 1992
Nature

Volume: 360, P: 33-39
Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMT

Juan Montoro
Allain-Thibeault Ferhat
Fabio Ciceri
Research03 Jul 2025
Bone Marrow Transplantation

P: 1-7
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML

Guillaume Dachy
Myriam Labopin
Mohamad Mohty
Research19 Jun 2025
Bone Marrow Transplantation

P: 1-7
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors

Allogeneic non-myeloablative stem-cell transplantation is feasible for patients with various refractory and advanced solid tumors. Current data suggest that the graft-versus-tumor effect associated with this approach might prolong survival of some patients with metastatic solid tumors. The authors discuss the latest results from the literature and recent data from the European Bone Marrow Transplantation Solid Tumors Working Party.

Taner Demirer
Lisbeth Barkholt
Marco Bregni
Reviews08 Apr 2008
Nature Clinical Practice Oncology

Volume: 5, P: 256-267
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT

Jaime Sanz
Myriam Labopin
Fabio Ciceri
Research12 Feb 2025
Bone Marrow Transplantation

Volume: 60, P: 529-534
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT

Arnon Nagler
Allain-Thibeault Ferhat
Fabio Ciceri
ResearchOpen Access29 May 2025
Bone Marrow Transplantation

P: 1-10
Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party

Nour Moukalled
Allain-Thibeault Ferhat
Fabio Ciceri
Research28 May 2025
Bone Marrow Transplantation

P: 1-9
Post-transplant cyclophosphamide with post-engraftment anti-thymocyte globulin reduce moderate to severe chronic graft-versus-host disease in peripheral stem cell transplantation from HLA-matched unrelated and haploidentical donors

Ying Wang
Wen-Hui Gao
Jiong Hu
Research22 Oct 2024
Bone Marrow Transplantation

Volume: 60, P: 58-63
Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning

Lining Wang
Guilin Xu
Jiong Hu
Research10 Apr 2024
Bone Marrow Transplantation

Volume: 59, P: 1006-1011
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

A molecular marker is required to monitor artemisinin-resistant Plasmodium falciparum parasites in southeast Asia; here mutations in K13-propeller are associated with artemisinin resistance in vitro and in vivo and also cluster in Cambodian provinces where resistance is prevalent.

Frédéric Ariey
Benoit Witkowski
Didier Ménard
Research18 Dec 2013
Nature

Volume: 505, P: 50-55
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome

Samia Harbi
Louison Brac de la Perriere
Raynier Devillier
Research03 Nov 2023
Bone Marrow Transplantation

Volume: 59, P: 101-106
Germline inherited small RNAs facilitate the clearance of untranslated maternal mRNAs in C. elegans embryos

In animal embryos, maternally deposited mRNAs are degraded by several different mechanisms. Here the authors show that C. elegans embryos inherit antisense pool of small RNAs which are loaded into CSR-1 and cleave complementary maternal mRNAs.

Piergiuseppe Quarato
Meetali Singh
Germano Cecere
ResearchOpen Access04 Mar 2021
Nature Communications

Volume: 12, P: 1-14
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party

Olaf Penack
Mouad Abouqateb
Zinaida Peric
ResearchOpen Access17 Apr 2025
Leukemia

Volume: 39, P: 1503-1511
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT

Mustafa Güven
Christophe Peczynski
Zinaida Peric
Research17 Apr 2025
Bone Marrow Transplantation

P: 1-8
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler
Myriam Labopin
Mohamad Mohty
Research23 Feb 2023
Bone Marrow Transplantation

Volume: 58, P: 552-557
Targeting natural killer cells and natural killer T cells in cancer

In this Review article, the authors describe the mechanisms by which natural killer cells and natural killer T cells can promote tumour cell elimination. Furthermore, they discuss the new therapies that are being used to boost the antitumour properties of these cells in the clinic.

Eric Vivier
Sophie Ugolini
Laurent Brossay
Reviews22 Mar 2012
Nature Reviews Immunology

Volume: 12, P: 239-252
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Iman Abou Dalle
Myriam Labopin
Mohamad Mohty
Research11 Apr 2023
Bone Marrow Transplantation

Volume: 58, P: 784-790
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Arnon Nagler
Myriam Labopin
Mohamad Mohty
Research30 Jun 2022
Bone Marrow Transplantation

Volume: 57, P: 1514-1519
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML

Avichai Shimoni
Myriam Labopin
Arnon Nagler
Research13 Jan 2022
Bone Marrow Transplantation

Volume: 57, P: 384-390
Small-RNA-mediated transgenerational silencing of histone genes impairs fertility in piRNA mutants

Barucci et al. show that the progressive loss of fertility in Caenorhabditis elegans lacking piRNAs is mediated by the epigenetic silencing of all of the replicative histone genes.

Giorgia Barucci
Eric Cornes
Germano Cecere
Research03 Feb 2020
Nature Cell Biology

Volume: 22, P: 235-245
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome

Luca Castagna
Thomas Pagliardini
Raynier Devillier
Research15 Nov 2020
Bone Marrow Transplantation

Volume: 56, P: 883-889
Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT

Frédéric Baron
Myriam Labopin
Mohamad Mohty
Research04 Sept 2020
Bone Marrow Transplantation

Volume: 56, P: 461-469
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT

Annalisa Paviglianiti
Myriam Labopin
Mohamad Mohty
Research28 Nov 2020
Bone Marrow Transplantation

Volume: 56, P: 1077-1085
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT

Leyre Bento
Ariane Boumendil
Anna Sureda
Research12 Oct 2020
Bone Marrow Transplantation

Volume: 56, P: 655-663
Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT

Annalisa Ruggeri
Myriam Labopin
Mohamad Mohty
Research05 Mar 2021
Bone Marrow Transplantation

Volume: 56, P: 1842-1849
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

Nico Gagelmann
Diderik-Jan Eikema
Nicolaus Kröger
Research24 Jul 2020
Bone Marrow Transplantation

Volume: 56, P: 210-217
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT

Frédéric Baron
Maud Ngoya
Mohamad Mohty
Research10 Jul 2021
Bone Marrow Transplantation

Volume: 56, P: 2742-2748
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

Mohamed A. Kharfan-Dabaja
Myriam Labopin
Mohamad Mohty
Research30 Apr 2021
Bone Marrow Transplantation

Volume: 56, P: 2194-2202
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Leopold Sellner
Johannes Schetelig
Peter Dreger
Amendments and CorrectionsOpen Access07 Oct 2021
Bone Marrow Transplantation

Volume: 56, P: 3108
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients

Angela Granata
Sabine Fürst
Raynier Devillier
Research19 Mar 2019
Bone Marrow Transplantation

Volume: 54, P: 1730-1737
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

Charlotte Nykolyszyn
Angela Granata
Raynier Devillier
Research18 Sept 2019
Bone Marrow Transplantation

Volume: 55, P: 349-355
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study

Katie S. Gatwood
Myriam Labopin
Arnon Nagler
Research16 Sept 2019
Bone Marrow Transplantation

Volume: 55, P: 224-232
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

Gwendolyn van Gorkom
Michel van Gelder
Nicolaus Kröger
Research18 Dec 2017
Bone Marrow Transplantation

Volume: 53, P: 255-263
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

Ling Wang
Raynier Devillier
Jiong Hu
ResearchOpen Access06 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 458-464
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients

Thomas Pagliardini
Samia Harbi
Raynier Devillier
Research06 Nov 2018
Bone Marrow Transplantation

Volume: 54, P: 1067-1076
Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT

Annalisa Ruggeri
Myriam Labopin
Arnon Nagler
Research31 May 2019
Bone Marrow Transplantation

Volume: 54, P: 1987-1994
Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

Raynier Devillier
Myriam Labopin
Mohamad Mohty
Research12 Jan 2018
Bone Marrow Transplantation

Volume: 53, P: 431-437
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide

Alexandros Spyridonidis
Myriam Labopin
Fabio Ciceri
Research05 Feb 2025
Bone Marrow Transplantation

Volume: 60, P: 499-506
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

Raynier Devillier
Jacques-Emmanuel Galimard
Mohamad Mohty
Research25 Jun 2022
Bone Marrow Transplantation

Volume: 57, P: 1421-1427
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

Thomas Heinicke
Myriam Labopin
Mohamad Mohty
Research23 Oct 2019
Bone Marrow Transplantation

Volume: 55, P: 729-739
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Post-transplantation relapse in acute myeloid leukemia patients without genomic loss of HLA is driven by transcriptional alterations in antigen presentation and T cell costimulation genes.

Cristina Toffalori
Laura Zito
Luca Vago
Research25 Mar 2019
Nature Medicine

Volume: 25, P: 603-611
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Matjaz Sever
Joanna Drozd-Sokolowska
Donal P. McLornan
Research12 Nov 2024
Bone Marrow Transplantation

Volume: 60, P: 211-219
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study

Guillermo Ortí
Christophe Peczynski
Zinaida Peric
Research19 Nov 2024
Leukemia

Volume: 39, P: 431-437
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP–EBMT

Simone Cesaro
Gloria Tridello
Jan Styczynski
Research29 Jan 2021
Bone Marrow Transplantation

Volume: 56, P: 1563-1572
Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis

Lining Wang
Wenhui Gao
Jiong Hu
Correspondence27 Jul 2024
Bone Marrow Transplantation

Volume: 59, P: 1491-1493
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT

Arnon Nagler
Myriam Labopin
Mohamad Mohty
Research20 Aug 2024
Bone Marrow Transplantation

Volume: 59, P: 1563-1576
Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler
Myriam Labopin
Mohamad Mohty
Research18 Aug 2024
Bone Marrow Transplantation

Volume: 59, P: 1552-1562
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT

Razan Mohty
Abdul Hamid Bazarbachi
Mohamad Mohty
Research14 Aug 2024
Bone Marrow Transplantation

Volume: 59, P: 1534-1541
REBOUND “Trained to live again”: The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantation

Didier Blaise
Sarah Calvin
Patrice Viens
Reviews02 Mar 2020
Bone Marrow Transplantation

Volume: 55, P: 997-999

Previous page
page 1
page 2
page 3
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Italy
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited